Articaine: A review of its use for localand regional anesthesia

Local and Regional Anesthesia

Volumn 5, Issue 1, 2013, Pages 23-33

  Snoeck, Marc ^a  

^a CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Articaine; Neurotoxicity; Pharmacodynamics; Pharmacokinetics; Regional anesthesia; Therapeutic use; Tolerability

Indexed keywords

ADRENALIN; ANESTHETIC AGENT; ARTICAINE; BUPIVACAINE; CHLOROPROCAINE; ETIDOCAINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MEPIVACAINE; OPIATE; PETHIDINE; PLASMA PROTEIN; PRILOCAINE; PROCAINE; SHORT ACTING ANALGESIC AGENT; TETRACAINE;

AMBULATORY CARE; ARTICLE; BIOACCUMULATION; CARDIOTOXICITY; CONFUSION; DENTAL PROCEDURE; DENTISTRY; DERMATOLOGY; DIPLOPIA; DIZZINESS; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE REDUCTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG STRUCTURE; EMULSION; EPIDURAL ANESTHESIA; HUMAN; INTRAVENOUS REGIONAL ANESTHESIA; LOCAL ANESTHESIA; MAXIMUM PLASMA CONCENTRATION; MUSCLE TWITCH; NERVE BLOCK; NEUROTOXICITY; OBSTETRIC ANESTHESIA; OCULAR ANESTHESIA; OPHTHALMOLOGY; OTORHINOLARYNGOLOGY; PAIN; PARESTHESIA; PERIPHERAL NERVE; POSTOPERATIVE PAIN; REGIONAL ANESTHESIA; REGIONAL NERVE BLOCK; RESTLESSNESS; SIDE EFFECT; SINGLE DRUG DOSE; SLURRED SPEECH; SPINAL ANESTHESIA; TASTE DISORDER; TINNITUS;

EID: 84876290869     PISSN: None     EISSN: 11787112     Source Type: Journal    
DOI: 10.2147/LRA.S16682     Document Type: Article

References (76)

1. McLure HA, Rubin AP. Review of local anaesthetic agents. Minerva Anestesiol. 2005;71:59-74.
2. Ferger P, Marxkors K. Ein neues Anästhetikum in der Zahnärztlichen Prosthetik. Dtsch Zahnarztl Z. 1973;28:87-89.
3. Hendolin H, Mattila M. Hoe-40045, ein neues Lokalanësthetikum verglichen mit Lidocain bei Epiduralanästhesie. Prakt Anaesth. 1974;9:178-182.
4. Brinkløv MM. Effectivity of carticaine, a new local anesthetic. A survey and a double blind investigation comparing carticaine with lidocaine in epidural analgesia. Acta Anaesth Scand. 1977;21:5-16.
5. Wang GK, Calderon J, Jaw SJ, Wang SY. State-dependent block of Na+ channels by articaine via the local anesthetic receptor. J Membr Biol. 2009;229:1-9.
6. Buckenmaier CC, Bleckner LL. Anaesthetic agents for advanced regional anaesthesia: a North American perspective. Drugs. 2005;65: 745-759.
7. Kokubu M, Oda K, Kudo M, Machida M, Shinya N. Correlation between the anesthetic potency of local anesthetics and their binding ability to a model membrane. J Anesth. 1979;11:121-125.
8. Vähätalo K, Antila H, Lehtinen R. Articaine and lidocaine for maxillary infiltration anesthesia. Anesth Prog. 1993;40:114-116.
9. Kaukinen S, Eerola R, Eerola M, Kaukinen L. Comparison ofcarticaine and lidocaine in spinal anaesthesia. Ann Clin Res. 1978;10:191-194.
10. Sack U, Kleemann PP. Intraoral conduction anesthesia with epinephrine-containing local anesthetics and arterial epinephrine plasma concentration. Anesth Pain Control Dent. 1992;1:77-80.
11. Mather LE, Tucker GT. Properties, absorption, and disposition of local anesthetic agents. In: Cousins MJ, Carr DB, Horlocker TT, Bridenbaugh PO, editors. Neural Blockade in Clinical Anesthesia and Pain Medicine, 4th ed. Philadelphia: Wolters Kluwer/Lippincott Williams and Wilkins; 2009:48-95.
12. Vree TB, Gielen MJ. Clinical pharmacology and the use of articaine for local and regional anaesthesia. Best Pract Res Clin Anaesthesiol. 2005;19:293-308.
13. Vree TB, Simon MA, Gielen MJM. Booij LHDJ. Regional metabolism of articaine in 10 patients undergoing intravenous regional anaesthesia during day case surgery. Br J Clin Pharmacol. 1997;44:29-34.
14. Grossmann M, Sattler G, Pistner H, et al. Pharmacokinetics of articaine hydrochloride in tumescent local anesthesia for liposuction. J Clin Pharmacol. 2004;44:1282-1289.
15. Calvo R, Carlos R, Erill S. Effects of disease and acetazolamide on procaine hydrolysis by red cell enzymes. Clin Pharmacol Ther. 1980;27:175.
16. De Martin S, Orlando R, Bertoli M. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving hemodialysis. Clin Pharmacol Ther. 2006;80:597-606.
17. Mazoit JX, Dalens BJ. Pharmacokinetics of local anaesthetics in infants and children. Clin Pharmacokinet. 2004;43:17-32.
18. Jakobs W, Ladwig B, Cichon P. Oertel R, Kirch W. Serum levels of articaine 2% and 4% in children. Anesth Prog. 1995;42:113-115.
19. Malamed SF, Gagnon S, Leblanc D. Efficacy of articaine: a new amide local anesthetic. Pediatr Dent. 2000;22:307-311.
20. Adewumi A, Hall M, Guelmann M, Riley J. The incidence of adverse reactions following 4% septocaine (articaine) in children. Pediatr Dent. 2008;30:424-428.
21. Wright GZ, Weinberger SJ, Friedman CS, Plotzke OB. Use of articaine local anesthesia in children under 4 years of age - a retrospective report. Anesth Prog. 1989;36:268-271.
22. Brickhouse TH, Unkel JH, Webb MB, Best AM, Hollowell RL. Articaine use in children among dental practitioners. Pediatr Dent. 2008;30:516-521.
23. Ochoa J, Mair WG. The normal sural nerve in man. II. Changes in the axons and Schwann cells due to ageing. Acta Neuropathol (Berl). 1969;13:217-239.
24. Dorfman LJ, Bosley TM. Age-related changes in peripheral and central nerve conduction in man. Neurology. 1979;29:38-44.
25. Hanks RK, Pietrobon R, Nielsen KC, et al. The effect of age on sciatic nerve block duration. Anesth Analg. 2006;102:588-592.
26. Verdu E, Ceballos D, Vilches JJ, Navarro X. Influence of aging on peripheral nerve function and regeneration. J Peripher Nerv Syst. 2000;5:191-208.
27. Werdehausen R, Fazeli S, Braun S, et al. Apoptosis induction by different local anaesthetics in a neuroblastoma cell line. Br J Anaesth. 2009;103:711-718.
28. Tsui BC, Wagner A, Finucane B. Regional anaesthesia in the elderly: a clinical guide. Drugs Aging. 2004;21:895-910.
29. Oertel R, Ebert U, Rahn R, Kirch W. The effect of age on pharmacokinetics of the local anesthetic drug articaine. Reg Anesth Pain Med. 1999;24:524-528.
30. Semenikhin AA, Kim ED. Prolonged epidural analgesia with ultracaine for labor pain relief. Anesteziol Reanimatol. 2001;2:28-30. Russian.
31. Kim ED, Seminikhin AA. Optimal modes of epidural analgesia at labor in females at a high risk of complications. Anesteziol Reanimatol. 2006;4:59-62. Russian.
32. Hamar O, Csömör S Jr, Tóth P, Markó J. Comparative evaluation of carticaine and bupivacaine in epidural anesthesia in cesarean section. Zentralbl Gynakol. 1986;108:739-743. German.
33. Kaukinen L, Kaukinen S, Kärkkäinen S. Epidural anesthesia with carticaine in cesarean section. A comparison with bupivacaine. Reg Anaesth. 1986;9:79-83. German.
34. Strasser K, Huch A, Huch R, Uihein M. Placental transfer of carticaine (ultracain) a new local anaesthetic agent. Z Geburtshilfe Perinatol. 1977;181:118-120. German.
35. Zsigmond EK, Downs JR. Plasma cholinesterase activity in newborns and infants. Can Anaesth Soc J. 1971;18:278-285.
36. Hoffman RS, Henry GC, Howland MA, Weisman RS, Weil L, Goldfrank LR. Association between life-threatening cocaine toxicity and plasma cholinesterase activity. Ann Emerg Med. 1992;21: 247-253.
37. Duysen EG, Lockridge O. Prolonged toxic effects after cocaine challenge in butyrylcholinesterase/plasma carboxylesterase double knockout mice: a model for butyrylcholinesterase-deficient humans. Drug Metab Dispos. 2011;39:1321-1323.
38. Kallio H, Snall EV, Luode T, Rosenberg PH. Hyperbaric articaine for day-case spinal anaesthesia. Br J Anaesth. 2006;97:704-709.
39. Ostgaard G, Hallaraker O, Ulveseth OK, Flaatten H. A randomised study of lidocaine and prilocaine for spinal anaesthesia. Acta Anaesth Scand. 2000;44:436-440.
40. Casati A, Danelli G, Berti M, Fioro A, Fanelli A, Benassi C.Intrathecal 2-chloroprocaine for outpatient lower limb surgery: a prospective, randomized, double-blind clinical evaluation. Anesth Analg. 2006;103:234-238.
41. Timmerman L, van Dongen EP, Tromp E, Andriessen EJ, Kerkvliet CT, Knibbe CA. Articaine and lidocaine for spinal anaesthesia in day case surgery. Reg Anesth Pain Med. 2007;32 Suppl 1:9.
42. Hendriks MP, de Weert CJ, Snoeck MM, Hu H, Pluim MA, Gielen MJ. Plain articaine or prilocaine for spinal anaesthesia in day-case knee arthroscopy: a double-blind randomized trial. Br J Anaesth. 2009;102:259-263.
43. Förster JG, Kallio H, Rosenberg PH, Harilainen A, Sandelin J, Pitkänen MT. Chloroprocaine vs articaine as spinal anaesthetics for day-case knee arthroscopy. Acta Anaesthesiol Scand. 2011;55:273-281.
44. Kozlov SP, Svetlov VA, Lukianov MV. Pharmacology of local anesthetics and clinical aspects of segmental blocking. II Spinal anesthesia. Anesteziol Reanimatol. 1998;5:37-42. Russian.
45. Dijkstra T, Reesink JA, Verdouw BC, Van der Pol WS, Feberwee T, Vulto AG. Spinal anaesthesia with articaine 5% vs bupivacaine 0.5% for day-case lower limb surgery: a double-blind randomized clinical trial. Br J Anaesth. 2008;100:104-108.
46. Bachmann M, Pere P, Kairaluoma P, Rosenberg PH, Kallio H. Randomized comparison of hyperbaric articaine and hyperbaric low-dose bupivacaine along with fentanyl in spinal anaesthesia for day-case inguinal herniorrhaphy. Eur J Anaesthesiol. 2012;29:22-27.
47. De Weert K, Traksel M, Gielen M, Slappendel R, Weber E, Dirksen R. The incidence of transient neurological symptoms after spinal anaesthesia with lidocaine compared to prilocaine. Anaesthesia. 2000;55:1020-1024.
48. Oss GE, Vree TB, Baars AM, Termond EF, Booij LH. Pharmacokinetics, metabolism and renal excretion of articaine and its metabolite articainic acid in patients after epidural administration. Eur J Anaesth. 1989;6:49-56.
49. Vree TB, Van Oss GE, Gielen MJM, Booij LHDJ. Epidural metabolism of articaine to its metabolite articainic acid in five patients after epidural administration of 600 mg articaine. J Pharm Pharmacol. 1997;49:158-163.
50. Noyan A, Cepel S, Ural S, Ozel A. Continuous cervical epidural anesthesia in hand surgery. J Reconstr Microsurg. 2001;17:481-485.
51. Veering BT, Cousins MJ. Epidural neural blockade. In: Cousins MJ, Carr DB, Horlocker TT, Bridenbaugh PO, editors. Neural Blockade in Clinical Anesthesia and Pain Medicine, 4th ed. Philadelphia: Wolters Kluwer/Lippincott Williams and Wilkins; 2009:241-295.
52. Simon MA, Gielen MJ, Alberink N, Vree TB, van Egmond J. Intravenous regional anesthesia (IVRA) with 0.5% articaine, 0.5% lidocaine, or 0.5% prilocaine. A double-blind randomized clinical study. Reg Anesth. 1997;22:29-34.
53. Pitkanen MT, Xu M, Haasio J, Rosenberg PH. Comparison of 0.5% articaine and 0.5% prilocaine in intravenous regional anesthesia of the arm: a cross-over study in volunteers. Reg Anesth Pain Med. 1999;24:131-135.
54. Cowan A. Clinical assessment of a new local anesthetic agent -carticaine. Oral Surg Oral Med Oral Pathol. 1977;43:174-180.
55. Yapp KE, Hopcraft MS, Parashos P. Articaine: a review of the literature. Br Dent J. 2011;210:323-329.
56. Yapp KE, Hopcraft MS, Parashos P. Dentists' perceptions of a new local anaesthetic drug - articaine. Aust Dent J. 2012;57:18-22.
57. Hintze A, Paessler L. Comparative investigations on the efficacy of articaine 4% (epinephrine 1:200,000) and articaine 2% (epinephrine 1:200,000) in local infiltration anaesthesia in dentistry - a randomised double-blind study. Clin Oral Investig. 2006;10:145-150.
58. Fritzsche C, Pässler L. Ultracain D-S und ultracain 2%-suprarenin-vergleichende untersuchungen zur lokalanästhesie in der zahnärztlichen chirurgie. Quintessenz. 2000;51:507-514.
59. Allman KG, McFadyen JG, Armstrong J, Sturrock GD, Wilson IH. Comparison of articaine and bupivacaine/lidocaine for single medial canthus peribulbar anaesthesia. Br J Anaesth. 2001;87:584-587.
60. Allman KG, Barker LL, Werrett GC, Gouws P, Sturrock GD, Wilson IH. Comparison of articaine and bupivacaine/lidocaine for peribulbar anaesthesia by inferotemporal injection. Br J Anaesth. 2002;88:676-678.
61. Gouws P, Galloway P, Jacob J, English W, Allman KG. Comparison of articaine and bupivacaine/lidocaine for sub-Tenon's anaesthesia in cataract extraction. Br J Anaesth. 2004;92:228-230.
62. Raman SV, Barry JS, Murjaneh S, et al. Comparison of 4% articaine and 0.5% levobupivacaine/2% lidocaine mixture for sub-Tenon's anaesthesia in phacoemulsification cataract surgery: a randomised controlled trial. Br J Ophthalmol. 2008;92:496-499.
63. Erkul E, Babayigit M, Kuduban O. Comparison of local anesthesia with articaine and lidocaine in septoplasty procedure. Am J Rhinol Allergy. 2010;24:123-126.
64. Schulze KE, Cohen PR, Nelson BR. Articaine: an effective adjunctive local anesthetic for painless surgery at the depth of the muscular fascia. Dermatol Surg. 2006;32:407-410.
65. Dogan N, Ucok C, Korkmaz C, Uycok O, Karasu HA. The effects of articaine hydrochloride on wound healing: an experimental study. J Oral Maxillofac Surg. 2003;61:1467-1470.
66. Gerner P, Strichartz GR. Sensory and motor complications of local anesthetics. Muscle Nerve. 2008;37:421-425.
67. Zaric D, Christiansen C, Pace NL, Punjasawadwong Y. Transient neurologic symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics. Cochrane Database Syst Rev. 2005;2:CD003006.
68. Pogrel MA. Permanent nerve damage from inferior alveolar nerve blocks - an update to include articaine. J Calif Dent Assoc. 2007;35:271-273.
69. Denson DD, Bridenbaugh PO, Turner PA, Phero JC. Comparison of neural blockade and pharmacokinetics after subarachnoid lidocaine in the rhesus monkey. II: Effects of volume, osmolality, and baricity. Anesth Analg. 1983;62:995-1001.
70. Nakamura T, Popitz-Bergez F, Birknes J, Strichartz GR. The critical role of concentration for lidocaine block of peripheral nerve in vivo: studies of function and drug uptake in the rat. Anesthesiology. 2003;99:1189-1197.
71. Mather LE, Copeland SE, Ladd LA. Acute toxicity of local anesthetics: underlying pharmacokinetic and pharmacodynamic concepts. Reg Anesth Pain Med. 2005;30:553-566.
72. Rosenberg PH, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: a multifactorial concept. Reg Anesth Pain Med. 2004;29:564-575.
73. Wolf JW, Butterworth JF. Local anesthetic systemic toxicity: update on mechanisms and treatment. Curr Opin Anesthesiol. 2011;24:561-566.
74. Drasner K. Local anesthetic toxicity: optimal management to avoid neurotoxic injury and treat cardiac arrest. ASA Refresher Courses in Anesthesiology. 2011;39:33-40.
75. Szabó A, Szentandrássy N, Birinyi P, et al. Effects of articaine on action potential characteristics and the underlying ion currents in canine ventricular myocytes. Br J Anaesth. 2007;99:726-733.
76. Szentandrássya N, Szabób A, Almássya J, et al. Effects of articaine and ropivacaine on calcium handling and contractility in canine ventricular myocardium. Eur J Anaesth. 2010;27:153-161.